Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-01
2006-08-01
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S498000
Reexamination Certificate
active
07084135
ABSTRACT:
A family of imidazole compounds useful for inhibiting the activity of prenyl transferases. The compounds are covered by formula (I): wherein X is (CHR11)n3(CH2)n4Z(CH2)n5where Z is O, N(R12), S, or a bond; Y is CO, CH2, CS, or a bond; R1is A, B, C, D, E, F, G, H, I, J or N(R24R25); and the remaining substituents are as defined in the disclosure
REFERENCES:
patent: 5488109 (1996-01-01), Olmstead et al.
patent: 216 967 (1999-10-01), None
patent: WO 97 30053 (1997-08-01), None
patent: WO 00 02881 (2000-01-01), None
Gordon Thomas D.
Morgan Barry A.
Coleman Brenda
Feeney Alan F.
Fish & Richardson
Morrill Brian R.
Societe de Conseils de Recherches et d'Applications Scientifique
LandOfFree
Prenyl transferase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prenyl transferase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prenyl transferase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3637234